Sponsor Pipeline

Liling Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06867536 Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory… Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Recruiting
NCT05976997 Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the… Newly Diagnosed Peripheral T-cell Lymphoma Recruiting
Disease Areas
DLBCL (1)
Get alerts when Liling Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free